Physician profile
Debbie Martinez
NPI 1154554343
$1,661.27
in general payments reported to CMS, 2019-2025
21 companies · $651 in 2025
The $651 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.12 · 2023: $474 · 2024: $515 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,640.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $596.51 | 2023-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $141.40 | 2023-2025 | Mounjaro |
| Novo Nordisk INC | $123.70 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $94.52 | 2023-2025 | |
| Abbvie INC. | $91.66 | 2023-2025 | |
| Dexcom, INC. | $63.40 | 2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $59.39 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $58.98 | 2025 | |
| Sumitomo Pharma America, INC. | $52.08 | 2024-2025 | Gemtesa |
| Medtronic, INC. | $49.30 | 2025 | Catalyft Pl Expandable Interbody System |
| Shield Therapeutics INC | $47.06 | 2023-2024 | Accrufer |
| Mannkind Corporation | $44.25 | 2025 | |
| Esperion Therapeutics, INC. | $43.76 | 2023-2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $41.97 | 2023-2024 | Breztri, Farxiga |
| Xeris Pharmaceuticals, INC. | $36.00 | 2025 | Gvoke Hypopen |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $32.25 | 2023 | Intracept |
| Bsn Medical INC | $21.12 | 2022 | |
| Merck Sharp & Dohme LLC | $17.08 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
| Idorsia Pharmaceuticals US INC | $16.54 | 2023 | Quviviq |
| Tactile Systems Technology INC | $15.35 | 2025 | Flexitouch Plus, Nimbl |
| Paratek Pharmaceuticals, INC. | $14.95 | 2023 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debbie Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.